FibroBiologics (FBLG) Other Working Capital Changes (2023 - 2026)
FibroBiologics' (FBLG) quarterly Other Working Capital Changes came in at -$69000.0 in Q2 2026, up 51.41% on a YoY basis from -$45572.1 in Q2 2025, and up 61.24% quarter-over-quarter from -$178000.0 in Q1 2026.
Powered by 
Analysis
FibroBiologics (FBLG) Other Working Capital Changes (2023 - 2026) Analysis & Trends
FibroBiologics (FBLG) has reported Other Working Capital Changes for 4 consecutive years, with -$69000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Working Capital Changes rose 51.41% year-over-year to -$69000.0; the trailing twelve-month figure through Jun 2026 stood at -$547000.0 (down 32.13% YoY), and the FY2025 full-year result was -$550000.0, down 51.93% from the prior year.
- Other Working Capital Changes advanced to -$69000.0 in Q2 2026 per FBLG's latest filing, from -$178000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $403000.0 in Q1 2026 and bottomed at -$403000.0 in Q2 2026.
- Historically, Other Working Capital Changes has averaged -$3750.0 across 4 years, with a median of -$8000.0 in 2024.
- The sharpest annual moves came in 2025 and 2026: Other Working Capital Changes tumbled 109.68% in 2025, then soared 51.41% in 2026.
- Over 4 years, Other Working Capital Changes stood at -$53000.0 in 2023, then slipped by 16.98% to -$62000.0 in 2024, then sank by 109.68% to -$130000.0 in 2025, then surged by 46.92% to -$69000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$69000.0, -$178000.0, and -$130000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn |
| 10 | FibroBiologics | 12.05 Mn | 12.05 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -69,000.00 |
| Jun 30, 2026 | -69,000.00 |
| Mar 31, 2026 | -178,000.00 |
| Mar 31, 2026 | -178,000.00 |
| Dec 31, 2025 | -130,000.00 |
| Dec 31, 2025 | -130,000.00 |
| Sep 30, 2025 | -170,000.00 |
| Sep 30, 2025 | -170,000.00 |
| Jun 30, 2025 | -142,000.00 |
| Jun 30, 2025 | -142,000.00 |
| Mar 31, 2025 | -108,000.00 |
| Mar 31, 2025 | -108,000.00 |
| Dec 31, 2024 | -62,000.00 |
| Dec 31, 2024 | -62,000.00 |
| Sep 30, 2024 | -102,000.00 |
| Sep 30, 2024 | -102,000.00 |
| Jun 30, 2024 | -100,000.00 |
| Jun 30, 2024 | -100,000.00 |
| Mar 31, 2024 | -98,000.00 |
| Mar 31, 2024 | -98,000.00 |